Takeda 2.3 mg (Ninlaro 2.3 mg)
Generic Name: ixazomib
Pill with imprint Takeda 2.3 mg is Pink, Capsule-shape and has been identified as Ninlaro 2.3 mg. It is supplied by Takeda Pharmaceutical Company Limited.
Ninlaro is used in the treatment of multiple myeloma and belongs to the drug class proteasome inhibitors. Ninlaro 2.3 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for Takeda 2.3 mg
Ninlaro
- Generic Name:
- ixazomib
- Imprint:
- Takeda 2.3 mg
- Strength:
- 2.3 mg
- Color:
- Pink
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Proteasome inhibitors
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Takeda Pharmaceutical Company Limited
- National Drug Code (NDC):
- 63020-0078
More about Ninlaro (ixazomib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: proteasome inhibitors
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
